• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0028667241
Device Problem Obstruction of Flow (2423)
Patient Problems Cardiac Enzyme Elevation (1838); Vomiting (2144); Thrombosis/Thrombus (4440)
Event Date 03/07/2023
Event Type  Injury  
Event Description
It was reported that thrombosis occurred.The patient presented with acute coronary syndrome for percutaneous coronary angioplasty.The 90% stenosed target lesion was located in the severely calcified proximal to mid left anterior descending artery (lad).Following pre-dilation with multiple balloons, the 2.75 x 20 synergy xd stent was implanted with no issues being reported.Four hours after the procedure, the patient suddenly started vomiting and an electrocardiogram (ekg) confirmed st-segment elevation.An angiographic examination revealed thrombotic occlusion with the 2.75 x 20mm synergy stent.When the thrombus was aspirated, the ekg improved.It was confirmed using intravascular ultrasound (ivus) that nodules derived from calcification were floating in the synergy stent, so an additional synergy was placed in the product.After placement, the floating calcifications disappeared, confirming good apposition.The final angiographic examination confirmed good flow and no perforation, so the procedure was terminated.The patient condition post procedure was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16621307
MDR Text Key312097766
Report Number2124215-2023-14291
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 03/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/05/2024
Device Lot Number0028667241
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/05/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-